Applied Genetic Technologies Corporation information
Biotechnology company
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article reads like a press release or a news article and may be largely based on routine coverage. Please help improve this article and add independent sources.(October 2017)
The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Applied Genetic Technologies Corporation" – news · newspapers · books · scholar · JSTOR(October 2017) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Applied Genetic Technologies Corporation
Company type
Public
Traded as
Nasdaq: AGTC Russell Microcap Index component
Industry
Biotechnology
Founded
January 19, 1999; 25 years ago (1999-01-19)
Headquarters
Alachua, Florida, United States
Key people
Susan B. Washer
(president & CEO)
William A. Sullivan (CFO)
Revenue
US$ 24.19 million
(FY JUN 30, 2018)
Operating income
US$ -22.38 million
(FY JUN 30, 2018)
Net income
US$ -21.30 million
(FY JUN 30, 2018)
Total assets
US$ 118.53 million
(FY JUN 30, 2018)
Total equity
US$ 99.18 million
(FY JUN 30, 2018)
Number of employees
78
(FY JUN 30, 2018)
Website
AGTC.com
Footnotes / references [1]
The Applied Genetic Technologies Corporation is a publicly traded[2] biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida.[3] In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer.[4]
The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis,[5][6] X-linked retinitis pigmentosa,[7] and age-related macular degeneration.[8] The company has six products in various stages of development; as of 2016, none had yet been approved.[9]
In January 2017, AGTC entered into a strategic research and development collaboration with Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding. Through the collaboration, AGTC and Bionic Sight will to develop a new optogenetic therapy that leverages AGTC's deep experience in gene therapy and ophthalmology.[10]
On January 9, 2020, the company reported positive results from a Phase 1/2 trial for its investigational gene therapy for retinitis pigmentosa.[11] A few weeks later, the company reported interim six-month data from the dose-escalation cohorts of its ongoing Phase 1/2 clinical programs in patients with achromatopsia due to mutation in the ACHM CNGB3 or ACHM CNGA3 genes.[12] Applied Genetic Technologies Corporation is a patient partner within the blinding eye disease and rare disease community, including organizations like Foundation for Fighting Blindness and Global Genes.[13]
^"US SEC: Form 10-K Applied Genetic Technologies Corporation". U.S. Securities and Exchange Commission. September 11, 2018. Retrieved December 1, 2018.
^"Applied Genetic Technologies Corporation (AGTC)". NASDAQ.com. Retrieved 4 January 2016.
^"Company Overview of Applied Genetic Technologies Corporation". Bloomberg. Retrieved November 15, 2016.
^Chen, Angela. "Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments". Wall Street Journal. Retrieved 4 January 2016.
^"AGTC Announces Data Evaluating the Natural History of Patients With X-Linked Retinoschisis at the 48th Annual Retina Society Meeting". Yahoo Finance. Retrieved 4 January 2016.[dead link]
^"Biogen enters eye-treatment arena with AGTC deal". Reuters. 2 July 2015. Retrieved 4 January 2016.
^Ballie, Katherine. "Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia". www.upenn.edu. Archived from the original on 27 October 2015. Retrieved 4 January 2016.
^"Finding Cures for Visual Disorders l Products". www.agtc.com. Archived from the original on 5 January 2016. Retrieved 4 January 2016.
^"AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phase 1/2 Clinical Trials in Achromatopsia". Applied Genetic Technologies Corporation. Retrieved 2020-03-04.
Applied Biosystems is one of various brands under the Life Technologies brand of Thermo Fisher Scientific corporation. The brand is focused on integrated...
Life TechnologiesCorporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems...
a separate, but related transaction, Danaher agreed with Life TechnologiesCorporation (Nasdaq: LIFE) to acquire the remaining 50% ownership position...
was the vice president of Research and Development at AppliedGeneticTechnologiesCorporation (Nasdaq: AGTC) and Calydon, Inc., the latter was acquired...
is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera...
Keysight Technologies was completed. Agilent announced it had completed the spin-off of its electronic measurement business, Keysight Technologies. Hewlett-Packard...
predecessor corporation was Invitrogen Corporation (formerly traded as Nasdaq: IVGN), headquartered in Carlsbad, California. In 2008, a merger between Applied Biosystems...
billionaire William Sullivan 1993, chief financial officer of AppliedGeneticTechnologiesCorporation Tarek Sultan 1986, CEO and Vice Chairman of Agility Logistics...
pre-implantation genetic screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities...
LGC Biosearch Technologies employs over 1,200 people across 4 countries. Part of the Genomics Division of LGC, Biosearch Technologies has a network of...
stone tools to the complex genetic engineering and information technology that has emerged since the 1980s. The term technology comes from the Greek word...
Emerging technologies are technologies whose development, practical applications, or both are still largely unrealized. These technologies are generally...
wait until a dangerous technology has been invented before they prepare mitigations. Emerging technologies are novel technologies whose development or practical...
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis...
self-sufficient companies or were acquired. Among them are: AppliedGeneticTechnologiesCorporation (AGTC) Bio Energy LLC Celunol (merged with Diversa as Verenium...
company became the separate PE Corporation. In 2022, a split of PerkinElmer resulted in one part, comprising applied, food and enterprise services businesses...
targets General-purpose technology – Technologies that can affect an entire economy at large scale Genetic use restriction technology – Methods for controlling...
acquired Life TechnologiesCorporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing....
Applied & Life Sciences". Sartorius. Retrieved 2022-09-16. "Sartorius Acquires Cell Line and Process Developer Cellca". GEN News Highlights. Genetic Engineering...
and expression, cellular analysis, drug discovery, and genetic identity. Promega Corporation was founded by Bill Linton in 1978 to provide restriction...
visualization and at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge...
recombination-based technologies for creating genetic diversity, known as its Molecular Breeding directed evolution platform. These technologies allow the generation...
Genetic discrimination occurs when people treat others (or are treated) differently because they have or are perceived to have a gene mutation(s) that...
Sykes Professor of Materials and Energy Technologies at the Harvard John A. Paulson School of Engineering and Applied Sciences who is working organic battery...
Valenzuela was recipient of the Chilean National Prize for Applied Sciences and Technologies in 2002 and is a member of the Chilean Academy of Sciences...
European polytechnic university model and stressed laboratory instruction in applied science and engineering. MIT is one of three private land-grant universities...
issued its two tracking stocks, and also changed its own name to PE Corporation. The Applied Biosystems group had earlier already been renamed PE Biosystems...
Genetically modified food controversies are disputes over the use of foods and other goods derived from genetically modified crops instead of conventional...
Global Information
